However, it has recently been shown that metastatic tumor cells often develop greater degree of TRAIL resistance [34], [35] and we observed that metastatic colon carcinoma cells are not sensitive to IFN-γ sensitization (Fig. 1A&B). This evidence concerns the gene IFNG and neoplasm.